A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. (Q64611789)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction. |
clinical trial |
Statements
A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction. (English)
0 references
August 2014
0 references
December 2015
0 references
1,267
0 references
18 year
0 references